Cargando…
Letter to the editor: Antimicrobial resistance data and treatment guidelines – challenges in the context of urine samples and mecillinam testing
Autores principales: | Abu Sin, Muna, Wohlfarth, Esther, Klingeberg, Anja, Eckmanns, Tim, Kresken, Michael, Kramme, Evelyn, Werner, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416577/ https://www.ncbi.nlm.nih.gov/pubmed/37561051 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.32.2300418 |
Ejemplares similares
-
Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20
por: Kresken, Michael, et al.
Publicado: (2022) -
Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine
por: Thulin, Elisabeth, et al.
Publicado: (2017) -
Mecillinam – Reversion of Resistance and How to Test It
por: Frimodt-Moller, Niels
Publicado: (2017) -
Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022) -
Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam
por: Fuchs, Frieder, et al.
Publicado: (2021)